
Science and Development Network
News, views and information about science, technology and the developing world
Red powder extracted from danshen
Shanghai Novanat Bioresources Co. Ltd.
In the United States a new drug can take years and hundreds of millions of dollars to research and develop. For developing countries this investment is prohibitive, which explains why more than 97 per cent of drugs produced in China are 'generic' versions of drugs developed elsewhere.
Lately, Chinese researchers developing new drugs have found a shortcut, writes Jia Hepeng. By identifying the active compounds in plants used in ancient traditional medicines, they are then able to develop new drugs from compounds they already know are effective.
The Chinese herb danshen, for instance, has been used for hundreds of years to treat a range of ailments including heart disease. Researchers have identified and isolated the active compounds and shown in clinical trials that they are indeed effective.
But this process is not always straightforward. Some remedies can use up to 20 of the thousands of plants used in traditional medicine. Even identifying the active compound in danshen took more than a decade. For medicines based on multiple plants, the challenge is greater.
Link to full China Daily article.
To read more about indigenous knowledge visit SciDev.Net's indigenous knowledge dossier.
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
All SciDev.Net material is free to reproduce providing that the source and author are appropriately credited. For further details see Creative Commons.
27 May 2012